| 000 | 01805 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515220312.0 | ||
| 264 | 0 | _c20100816 | |
| 008 | 201008s 0 0 eng d | ||
| 022 | _a1440-1746 | ||
| 024 | 7 |
_a10.1111/j.1440-1746.2009.06207.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKudo, Masatoshi | |
| 245 | 0 | 0 |
_aThe 2008 Okuda lecture: Management of hepatocellular carcinoma: from surveillance to molecular targeted therapy. _h[electronic resource] |
| 260 |
_bJournal of gastroenterology and hepatology _cMar 2010 |
||
| 300 |
_a439-52 p. _bdigital |
||
| 500 | _aPublication Type: Lecture | ||
| 650 | 0 | 4 | _aAlgorithms |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBenzenesulfonates _xadministration & dosage |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xblood |
| 650 | 0 | 4 | _aContrast Media |
| 650 | 0 | 4 | _aEarly Detection of Cancer |
| 650 | 0 | 4 | _aGadolinium DTPA |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusion Pumps |
| 650 | 0 | 4 |
_aJapan _xepidemiology |
| 650 | 0 | 4 |
_aLiver Neoplasms _xblood |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMass Screening |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
| 650 | 0 | 4 | _aPhenylurea Compounds |
| 650 | 0 | 4 | _aPopulation Surveillance |
| 650 | 0 | 4 |
_aProtein Precursors _xblood |
| 650 | 0 | 4 | _aProthrombin |
| 650 | 0 | 4 |
_aPyridines _xadministration & dosage |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aSorafenib |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aalpha-Fetoproteins _xmetabolism |
| 773 | 0 |
_tJournal of gastroenterology and hepatology _gvol. 25 _gno. 3 _gp. 439-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1440-1746.2009.06207.x _zAvailable from publisher's website |
| 999 |
_c19730512 _d19730512 |
||